Herceptin Biosimilars Market Business Status and Future Outlook...

ha aggiunto una foto Altre informazioni

2025-09-18 09:34:14 -

Introduction The Herceptin Biosimilars Market refers to the segment of biopharmaceuticals that replicate the therapeutic effects of Herceptin (trastuzumab), a monoclonal antibody used in the treatment of HER2-positive breast cancer and HER2-positive gastric cancer. Biosimilars are biologic medical products that are highly similar to already approved...

0 Commenti 0 condivisioni 2 Views